UNH

• GAAP EPS was $6.04; adjusted EPS was $6.38.
• Full-year 2026 GAAP EPS outlook raised to $18.45-$18.95; adjusted EPS outlook raised to $19.50-$20.00.
• UnitedHealthcare served 48.5 million consumers with revenues of $86.0 billion and operating margin of 4.6%.
• Optum generated revenues of $65.7 billion and earnings from operations of $4.0 billion, with 160 bps margin expansion year-over-year.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• UnitedHealth Group held its 2026 Annual Meeting of Shareholders on June 1, 2026, with 768,066,717 shares represented.
• The non-binding advisory vote on executive compensation was approved with 559,434,838 votes for (82.74% of votes cast).
• The appointment of Deloitte & Touche LLP as independent auditor for fiscal year 2026 was ratified with 729,713,547 votes for (95.00%).
• A shareholder proposal to require an independent board chair was not approved, receiving only 20.24% of votes cast in favor.

5.07 Submission of Matters to a Vote of Security Holders

• UnitedHealth Group senior leaders will answer questions in an interview format at the Bank of America Securities Health Care Conference 2026.
• Discussion topics include the Company's strategy, market positions, recent results, and expectations for its end markets.
• A live audio webcast will be available on the Investor Relations page of UnitedHealth Group's website.
• The information is furnished under Regulation FD and is not deemed filed for SEC purposes.

7.01 Regulation FD Disclosure

• First quarter 2026 revenues were $111.7 billion, up 2% year-over-year from $109.6 billion.
• Full year 2026 earnings outlook raised to greater than $17.35 per share; adjusted earnings greater than $18.25 per share.
• Medical care ratio improved to 83.9%, down 90 basis points from the prior year quarter.
• Company agreed to acquire Alegeus Technologies and completed sale of Optum UK, with $400 million net proceeds committed to United Health Foundation.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• UnitedHealth Group senior leaders will answer questions in an interview format at the Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026, at 11:30 a.m. Eastern Time.
• A live audio webcast will be available through the Investor Relations page of UnitedHealth Group's website at www.unitedhealthgroup.com.
• The disclosure is being made under Item 7.01 Regulation FD and will not be deemed 'filed' for SEC purposes.

7.01 Regulation FD Disclosure

• Dennis Stankiewicz, age 48, was appointed Chief Accounting Officer effective March 2, 2026, and will continue as Corporate Controller.
• His compensation includes an annual base salary of $550,000 and an initial annual cash bonus target of 85% of base salary.
• He will receive severance equal to one times base salary if terminated without cause, subject to a non-compete condition.
• Tom Roos, the prior Chief Accounting Officer since August 2015, will become CFO of Optum Insight effective March 2, 2026.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

• The amendment adds a two-year share holding requirement following three-year cliff vesting.
• Mr. Hemsley must hold net shares acquired upon exercise until May 14, 2030, except in case of death or disability.
• All other terms of the stock option remain unchanged.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

• Full year 2025 earnings were $13.23 per share; adjusted earnings were $16.35 per share.
• Fourth quarter 2025 net earnings were $0.01 per share; adjusted earnings were $2.11 per share.
• 2026 revenue outlook is greater than $439.0 billion; adjusted earnings outlook is greater than $17.75 per share.
• Fourth quarter 2025 charge of $1.6 billion net of taxes, or $1.78 per share, included cyberattack costs, divestitures, and restructuring.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits